Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial.

Hidehito HorinouchiKaoru KubotaAkihiko MiyanagaShinji NakamichiMasahiro SeikeAkihiko GemmaYuki YamaneFutoshi KurimotoHiroshi SakaiShintaro KandaYutaka FujiwaraHiroshi NokiharaNoboru YamamotoTomohide TamuraYuichiro Ohe

Published in: ESMO open (2018)

UMIN000010201.

Keyphrases

phase iii
study protocol
phase ii
high dose
clinical trial
double blind
cross sectional
randomized controlled trial
open label
low dose
placebo controlled